Joanne E. Kavanagh
Guy's And St Thomas' Hospitals
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Identifying the residual unmet need in severe asthma.
Journal: The Lancet. Respiratory medicine
Published: May 29, 2026
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma.
Journal: The European respiratory journal
Published: February 20, 2023
A pragmatic guide to choosing biologic therapies in severe asthma.
Journal: Breathe (Sheffield, England)
Published: September 24, 2021
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy.
Journal: The European respiratory journal
Published: December 16, 2020
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.
Journal: The journal of allergy and clinical immunology. In practice
Published: December 08, 2020
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma.
Journal: Allergy
Published: October 14, 2020
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 13, 2020
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma.
Journal: Allergy
Published: August 19, 2020
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
Journal: Chest
Published: June 01, 2020
Last Updated: 09/26/2026